Method and apparatus for measuring glucose in body fluids using sub-dermal body tissue impedance measurements

• US 9,833,178 B2
• Filed: 05/04/2015
• Issued: 12/05/2017
• Est. Priority Date: 02/05/2004
• Status: Active Grant

• Current Assignee: D.T.R. Dermal Therapy Research Inc.
• Original Assignee: D.T.R. Dermal Therapy Research Inc.
• Inventors: Aberg, Peter, Ollmar, Stig, Birgersson, Ulrik, Neiderud, Fredrik
• Primary Examiner(s): JANG, CHRISTIAN YONGKYUN
• Application Number:
  US14/703,590
• Publication Number:
  US 20160007891A1
• Time in Patent Office: 946 Days
• CPC Class Codes: A61B 5/053 Measuring electrical impedance or conductance of a portion of the body
• CPC Class Codes: A61B 5/0538 invasively, e.g. using a catheter
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/318 Heart-related electrical modalities, e.g. electrocardiography [ECG]
• CPC Class Codes: A61B 5/7278 Artificial waveform generation or derivation, e.g. synthesising signals from measured signals A61B5/327 takes precedence
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00

Abstract

A method and an apparatus for measuring glucose level in the body fluid of a subject, typically blood glucose level, by measuring impedance of a body tissue, with two pairs of electrodes, two electrodes for injecting current into a body tissue and two electrodes for detecting the ensuing voltage of the body tissue. The body tissue is typically a sub-dermal or sub-cutaneous tissue. The measured impedance of the body tissue is used to correlate with directly determined glucose levels to determine the glucose level from the measured impedance. It is thus possible to determine body fluid glucose levels in a reliable and reproducible manner.

Claims

1. A method for measuring or monitoring blood glucose level in a subject, the method comprising:

injecting an electrical current into a body tissue of the subject using a first pair of injection electrodes;

detecting a voltage caused by the current flowing through the body tissue using a second pair of sensing electrodes;

measuring the impedance of the body tissue using a device for measuring impedance operatively connected to the pair of sensing electrodes; and

,

calculating the blood glucose level in the subject as a function of the measured impedance including correlating the measured impedance with a predetermined relationship between impedance and glucose levels.

2. The method of claim 1, wherein the injection electrodes and the sensing electrodes are inserted into the sub-dermal or subcutaneous body tissue of the subject.

3. The method of claim 1, wherein the sub-dermal body tissue is muscle, fat or blood vessels.

4. The method of claim 1, wherein the injection electrodes and the sensing electrodes are in a 4-point arrangement.

5. The method of claim 1, wherein said electrical current is provided at a frequency of less than 10 MHz.

6. The method of claim 5, wherein the electrical current is provided at a frequency of 1 MHz to 10 MHz.

7. The method of claim 5, wherein the electrical current is an alternating current.

8. The method of claim 1, wherein the microprocessor is operatively connected to an insulin pump and is further programmed to adjust the amount of insulin flow via the pump to the subject based on the calculated blood glucose level.

9. The method of claim 1, wherein the injection electrodes and the sensing electrodes are contained in a housing and wherein the housing is implanted within the body of the subject.

10. The method of claim 9, wherein the step of measuring the impedance involves an impedance measuring device and wherein the impedance measuring device is contained within the housing.

11. The method of claim 9, wherein the blood glucose level is calculated by a microprocessor programmed to determine the blood glucose level in the subject by correlating the measured impedance with a predetermined relationship between impedance and glucose levels and wherein the microprocessor is contained within the housing.